Ohm, regarding your prior post about RLFTF drug having poor trial outcome, can you explain this more? When was the trial? I read that interim would be in a few days and I don’t find what you’re talking about. Also, do they have a shelf offering lurking around? The company isn’t listed on Edgar and dilution could send it plummeting. What are your thoughts in general on this competition? Thanks. I know many here have shares in this company and I was thinking of getting some also.